OTCMKTS:AOXG Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis $0.0050 0.00 (-28.57%) As of 11:26 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Aoxing Pharmaceutical Stock (OTCMKTS:AOXG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aoxing Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.0050▼$0.005050-Day Range$0.0055▼$0.010752-Week Range$0.0046▼$0.0178Volume12,000 shsAverage Volume69,814 shsMarket Capitalization$1.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aoxing Pharmaceutical (OTCMKTS: AOXG) is a China-based company engaged in the research, development, manufacture and sale of active pharmaceutical ingredients (APIs), intermediates and finished dosage forms. The company’s product portfolio includes a variety of small-molecule APIs and botanical extracts designed to meet the needs of pharmaceutical, nutraceutical and cosmetic customers. Aoxing Pharmaceutical also offers custom synthesis and contract manufacturing services to support specialized client requirements. Headquartered in China, Aoxing Pharmaceutical operates manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards and other quality protocols. Its in-house R&D team focuses on process optimization, scale-up of new compounds and continuous improvement of production efficiencies. These capabilities enable the company to maintain tight quality control over its product lines and support ongoing pipeline development. Traded under the ticker AOXG on the OTC Markets, Aoxing Pharmaceutical serves domestic Chinese customers alongside select international partners in Asia and other regions. Its end markets include pharmaceutical manufacturers, healthcare providers and research institutions. The company continues to explore growth through expansion of its API offerings, enhancements in manufacturing technology and collaborations aimed at broadening its geographic footprint.AI Generated. May Contain Errors. Read More Receive AOXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aoxing Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AOXG Stock News HeadlinesTeva Pharmaceutical Industries Limited (TEVA)April 20, 2024 | finance.yahoo.comAoxing Pharmaceutical Company, Inc. (AOXG)January 23, 2024 | finance.yahoo.com2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematically extracting profits from the $4 billion that changes hands in crypto every single day.September 17 at 2:00 AM | Crypto Swap Profits (Ad)Aoxing Pharmaceutical Co Inc AOXGDecember 16, 2023 | morningstar.comMOPHLY Ono Pharmaceutical Co., Ltd.November 23, 2023 | seekingalpha.comAoxing Pharmaceutical Co (OTC:AOXG), Analyst Ratings, Price Targets, PredictionsJuly 12, 2022 | benzinga.comSee More Headlines AOXG Stock Analysis - Frequently Asked Questions How have AOXG shares performed this year? Aoxing Pharmaceutical's stock was trading at $0.0071 at the beginning of the year. Since then, AOXG shares have decreased by 29.6% and is now trading at $0.0050. How were Aoxing Pharmaceutical's earnings last quarter? Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) released its quarterly earnings data on Monday, May, 16th. The company reported $0.01 EPS for the quarter. The business earned $6.56 million during the quarter. How do I buy shares of Aoxing Pharmaceutical? Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aoxing Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), AcelRx Pharmaceuticals (ACRX), Ballard Power Systems (BLDP), CTI BioPharma (CTIC) and EDAP TMS (EDAP). Company Calendar Last Earnings5/16/2016Today9/17/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:AOXG Previous SymbolNYSEMKT:AXN CIKN/A Webaxzyen.icm.cn Phone(646) 367-1747Fax646-367-1747Employees350Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares381,209,000Free Float313,354,000Market Cap$1.91 million OptionableNot Optionable Beta7.38 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:AOXG) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aoxing Pharmaceutical Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aoxing Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.